- Home
- IVVD vs BLNK Comparison
IVVD vs BLNK Comparison
Compare IVVD & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- BLNK
- Stock Information
- Founded
- IVVD 2020
- BLNK 2009
- Country
- IVVD United States
- BLNK United States
- Employees
- IVVD N/A
- BLNK N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- BLNK Industrial Specialties
- Sector
- IVVD Health Care
- BLNK Consumer Discretionary
- Exchange
- IVVD Nasdaq
- BLNK Nasdaq
- Market Cap
- IVVD 69.0M
- BLNK 77.3M
- IPO Year
- IVVD 2021
- BLNK N/A
- Fundamental
- Price
- IVVD $0.74
- BLNK $0.97
- Analyst Decision
- IVVD Strong Buy
- BLNK Buy
- Analyst Count
- IVVD 3
- BLNK 8
- Target Price
- IVVD $5.85
- BLNK $2.61
- AVG Volume (30 Days)
- IVVD 1.3M
- BLNK 4.3M
- Earning Date
- IVVD 08-13-2025
- BLNK 08-06-2025
- Dividend Yield
- IVVD N/A
- BLNK N/A
- EPS Growth
- IVVD N/A
- BLNK N/A
- EPS
- IVVD N/A
- BLNK N/A
- Revenue
- IVVD $36,688,000.00
- BLNK $109,383,000.00
- Revenue This Year
- IVVD $446.60
- BLNK N/A
- Revenue Next Year
- IVVD $112.63
- BLNK $31.15
- P/E Ratio
- IVVD N/A
- BLNK N/A
- Revenue Growth
- IVVD N/A
- BLNK N/A
- 52 Week Low
- IVVD $0.35
- BLNK $0.63
- 52 Week High
- IVVD $2.74
- BLNK $3.75
- Technical
- Relative Strength Index (RSI)
- IVVD 48.03
- BLNK 55.64
- Support Level
- IVVD $0.70
- BLNK $0.88
- Resistance Level
- IVVD $0.77
- BLNK $1.10
- Average True Range (ATR)
- IVVD 0.05
- BLNK 0.08
- MACD
- IVVD -0.00
- BLNK 0.00
- Stochastic Oscillator
- IVVD 45.94
- BLNK 56.43
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.